Akebia Therapeutics: HC Wainwright Raises PT to $6, Maintains Buy Rating

martes, 2 de diciembre de 2025, 7:17 am ET1 min de lectura
AKBA--

Akebia Therapeutics: HC Wainwright Raises PT to $6, Maintains Buy Rating

Akebia Therapeutics: HC Wainwright Raises PT to $6, Maintains Buy Rating

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios